voice search
Glimepiride - Third Generation Sulfonylurea | Potent, Medium-to-long Acting Anti-diabetic Drug
Share

Glimepiride - Third Generation Sulfonylurea | Potent, Medium-to-long Acting Anti-diabetic Drug

Price:

Get Latest Price

In Stock

In Stock

Product Overview

Key Features

We expertise in formulating Glimepiride that belongs to the first third-generation of sulfonylurea. These are very potent sulfonylurea anti-diabetic drug and are medium-to-long acting and effective in the treatment of diabetes. Marketed as Amaryl by Sanofi-Aventis and as Diapride by Micro Labs Ltd. These drugs are in high demand all across the globe.

Company Details

Vaishali Pharma Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, is exclusively dedicated in supplying their own Branded Products followed by Generic finished products along with Surgical & Nutraceutical Range more than 40 countries. It has been awarded as. The Most Prestigious Brand in Asia by BARC in 2018 - 19. The Company is listed on National Stock Exchange of India as VAISHALI. It is also accredited as One Star Export House with a hold of 200+ Ready Brands with Dossiers and COPP registered in different parts of this world.

Business Type

Exporter, Manufacturer, Service Provider, Supplier, Trading Company

Employee Count

35

Establishment

1989

Working Days

Monday To Saturday

GST NO

27AACCV7258G1Z1

Payment Mode

Telegraphic Transfer (T/T)

Certification

IS0 9001:2000

Related Products

More Product From This seller

Seller Details

GST

GST - 27AACCV7258G1Z1

Mumbai, Maharashtra

Business Development Manager

Mr Kevin

Members since

5 Years

Address

706-709, 7th Floor, Aravali Business Centre, R.C. Patel Road, Borivali West, Mumbai, Maharashtra, 400092, India

glimepiride in Mumbai

Report incorrect details

Compare With Similar Products

Buyer Feedback

4

3

Color

Multi Color

Blue

Payment Terms

Cash Against Delivery (CAD)

Cash Against Delivery (CAD)

Main Domestic Market

All India

All India